Page last updated: 2024-10-19
2,3,4,5-tetrahydroxypentanal and Chronic Kidney Diseases
2,3,4,5-tetrahydroxypentanal has been researched along with Chronic Kidney Diseases in 1 studies
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Nephrotoxicity is a major toxic effect in chemotherapy, which constitutes up to 60% of hospitalized acute kidney injury (AKI)." | 1.48 | Galectin 3 inhibition attenuates renal injury progression in cisplatin-induced nephrotoxicity. ( Feng, JX; Li, HY; Li, JC; Yang, S, 2018) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Li, HY | 1 |
| Yang, S | 1 |
| Li, JC | 1 |
| Feng, JX | 1 |
Other Studies
1 other study available for 2,3,4,5-tetrahydroxypentanal and Chronic Kidney Diseases